Clinical trial
Umbilical Cord Blood Transplantation in Treating Patients With High-Risk…
NCT00003335 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003335 |
|---|---|
| Title | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer |
| Official title | A Pilot Study of Unrelated Umbilical Cord Blood Transplantation in Patients With High Risk Hematologic Malignancies |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | anti-thymocyte globulin, busulfan, cyclosporine, melphalan, methylprednisolone, umbilical cord blood transplantation, radiation therapy |
| Enrollment | 44 |
| Start date | Jan 1, 1998 |
| Primary completion | Nov 1, 2007 |
| Completion | Jan 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 15, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: